, Singapore
120 views

SGX welcomes medical technology firm Biolidics to Catalist

Biolidics debuted at $0.265.

Medical technology firm Biolodics has joined the Singapore Exchange’s (SGX) Catalist board, an announcement revealed.

The firm focuses on developing cell enrichment systems which, when combined with other analytical tests, have a wide range of applications for the treatment of cancer including diagnosis, prognosis, treatment selection and monitoring, the statement highlighted.

“With Biolidics’ novel patented technology to separate and enrich cancer cancer cells from blood, there is great potential for Biolidics’ chances to grow and successfully exploit the opportunities in the cancer diagnostics industry,” Biolidics’ CEO and executive director said in a statement.

Biolidics debuted at $0.265, according to SGX.

With a market capitalisation of approximately $68m, Biolidics’ listing brings the total number of companies listed on Catalist to 214 with a combined market capitalisation of more than $10b, SGX noted. The latest listing is expected to strengthen SGX’s healthcare cluster which comprises of 40 companies with a combined market capitalisation of more than $70b.

“Singapore houses one of the region’s biggest medical technology clusters and is at the forefront of many developments on the medical front,” Mohammed Nasser Ismail, SGX head of equity capital market (SME) and capital market development, said in a statement. 

Join Singapore Business Review community
Join Singapore Business Review community
A NOTE FROM SINGAPORE BUSINESS REVIEW

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.

Top News

Access Partnership closes $16.6m raise with Mayfair and Kartesia
The firm plans to use the capital for acquisitions and to deepen its global footprint.
Saudi Arabia may set up crude oil storage in Singapore
The joint venture will commence in Jurong Island in the second half of 2027.